Press Releases AxoGen, Inc.

Equities

AXGN

US05463X1063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.63 ^USD	+1.69%		+2.00%	-2.93%

Mar. 08	Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	MT
Mar. 08	AxoGen, Inc. Announces Executive Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	GL
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	AQ
AxoGen: Q4 Earnings Snapshot	Mar. 05	AQ
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	GL
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	AQ
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024	Feb. 13	GL
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Feb. 02	GL
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Feb. 02	AQ
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap	Jan. 18	GL
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023	Jan. 04	GL
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023	Jan. 04	AQ
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025	Jan. 04	GL
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025	Jan. 04	AQ
Axogen Announces Promotions on Research and Development Team	Jan. 04	GL
Axogen Announces Promotions on Research and Development Team	Jan. 04	AQ
Axogen, Inc. Appoints Kathy Weiler to its Board of DirectorsWeiler brings 20+ years of strategic and commercial leadership experience to the Axogen, Inc. Board of Directors	Dec. 27	AQ
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors	Dec. 26	GL
Axogen Announces Transition of Finance Team Leadership	Dec. 06	GL
Axogen Announces Transition of Finance Team Leadership	Dec. 06	AQ
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AxoGen, Inc.

Equities

AXGN

US05463X1063

Press Releases

Filters